Third Rock Ventures, a life sciences venture firm founded by four ex-Millennium Pharma executives, are looking to raise $300 million for its inaugural fund. The team includes former Millennium CEO Mark Levin, who was a partner with Mayfield up until 1994. News of the fund was first reported by a new biopharma market blog called In Vivo.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.